Literature DB >> 19704262

dcDegenerate oligonucleotide primed-PCR for multilocus, genome-wide analysis from limited quantities of DNA.

Michelle D Bonnette1, Victoria R Pavlova, Denise N Rodier, Lindsay P Thompson, Edward L Boone, Kelly L Brown, Kristin M Meyer, Michelle B Trevino, Jarrod R Champagne, Tracey Dawson Cruz.   

Abstract

This study modified the degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR)-based whole genome amplification method for improvement of downstream genome-wide analysis of low copy number DNA samples (<or= 0.100 ng). Experiments involved altering the degeneracy of the DOP primer, nonspecific cycle number, and adding proofreading polymerases. Increasing the degeneracy of the primer and the number of cycles that use a low annealing temperature should improve the nonspecific amplification of the DOP-PCR reaction. The addition of proofreading enzymes should allow for longer amplification products, increasing the genome coverage of the reaction. Low-input DNA quantities were examined for the primer and the cycle number studies using standard DOP-PCR parameters. The optimized DOP-PCR technique was then implemented for the polymerase study. All DOP-PCR products were amplified by using a multiplex microsatellite amplification kit to evaluate products from multiple chromosomes, followed by separation and detection by capillary electrophoresis. The 10 N primer, 12 nonspecific cycles, and the addition of the DeepVent proofreading enzyme all significantly increased the number of short tandem repeat alleles successfully amplified. All modifications also lowered the rate of allele drop-in, or sporadic additional allele occurrence, when compared with DOP-PCR results published earlier. Further, an average of > 0.50 intralocus heterozygote peak ratios were observed for most DNA input quantities examined. These results show that modifications of the traditional DOP-PCR reaction (dcDOP-PCR) to include the use of a more degenerate primer (10 N), 12 nonspecific cycles, and a proofreading enzyme allows for a more complete, balanced chromosome amplification from limited and/or compromised clinical and biological samples.

Mesh:

Substances:

Year:  2009        PMID: 19704262     DOI: 10.1097/PDM.0b013e31818d34d1

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  7 in total

1.  DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression.

Authors:  Kelong Ma; Yinghua He; Hongyu Zhang; Qi Fei; Dandan Niu; Dongmei Wang; Xia Ding; Hua Xu; Xiaoping Chen; Jingde Zhu
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

Review 2.  Whole genome amplification in preimplantation genetic diagnosis.

Authors:  Ying-ming Zheng; Ning Wang; Lei Li; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2011-01       Impact factor: 3.066

Review 3.  Whole Genome Amplification in Preimplantation Genetic Testing in the Era of Massively Parallel Sequencing.

Authors:  Ludmila Volozonoka; Anna Miskova; Linda Gailite
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

4.  MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.

Authors:  Youguang Pu; Fangfang Zhao; Wenjing Cai; Xianghui Meng; Yinpeng Li; Shanbao Cai
Journal:  Clin Exp Metastasis       Date:  2016-02-25       Impact factor: 5.150

5.  MiR-193a regulates chemoresistance of human osteosarcoma cells via repression of IRS2.

Authors:  Haiyan Wang; Fangfang Zhao; Shanbao Cai; Youguang Pu
Journal:  J Bone Oncol       Date:  2019-05-11       Impact factor: 4.072

Review 6.  Recent advances and application of whole genome amplification in molecular diagnosis and medicine.

Authors:  Xiaoyu Wang; Yapeng Liu; Hongna Liu; Wenjing Pan; Jie Ren; Xiangming Zheng; Yimin Tan; Zhu Chen; Yan Deng; Nongyue He; Hui Chen; Song Li
Journal:  MedComm (2020)       Date:  2022-02-03

Review 7.  New Perspectives for Whole Genome Amplification in Forensic STR Analysis.

Authors:  Richard Jäger
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.